Search Within

Department of Medicine

Formats
  1. Journal Article (19590)
  2. Meeting Abstract (16038)
  3. Review (1149)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22319)
  2. Hematologic Malignancies, Division of (13274)
  3. Center for Hematologic Malignancies (11058)
  4. GSK Faculty (10645)
  5. Survivorship Research (9329)
  6. Division of Subspecialty Medicine (7534)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1064)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4215)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2110)

More Publishers

Results (39615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Progressive plasticity during colorectal cancer metastasis
    Journal Article

    Moorman, A. R.; Benitez, E. K.; Cambuli, F.; Jiang, Q.; Mahmoud, A.; Lumish, M.; Hartner, S.; Balkaran, S.; Bermeo, J.; Asawa, S.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Predictors of recurrence in non-metastatic appendiceal epithelial cancers—An updated single center experience over 25 years
    Miscellaneous

    Aguirre, N.; Chung, S. K.; Foote, M. B.; Shia, J.; Vakiani, E.; Gowda, T.; Paty, P. B.; Weiser, M. R.; Garcia-Aguilar, J.; Karagkounis, G.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: Results from a large retrospective cohort
    Journal Article

    Melica, G.; Luna de Abia, A.; Shah, G. L.; Devlin, S.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Palomba, M. L.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Helicobacter pylori infection in the United States beyond NHANES: A scoping review of seroprevalence estimates by racial and ethnic groups
    Review

    McMahon, M. V.; Taylor, C. S.; Ward, Z. J.; Alarid-Escudero, F.; Camargo, M. C.; Laszkowska, M.; Roa, J.; Yeh, J. M.
    The Lancet Regional Health - Americas (2025)

    Fulltext@MSK | Save
  • Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Journal Article

    Shadman, M.; Salkar, M.; Srivastava, B.; Karve, S.; Emond, B.; Gogna, P.; Manceur, A. M.; Lafeuille, M. H.; Rava, A.; Sun, H.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Journal Article

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G. K.; Borge, P. D.; Geyer, M.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Birth cohort and age-specific trends in global Helicobacter pylori seroprevalence: A scoping review
    Review

    Taylor, C. S.; McMahon, M. V.; Ward, Z. J.; Alarid-Escudero, F.; Camargo, M. C.; Laszkowska, M.; Roa, J.; Yeh, J. M.
    The Lancet Regional Health - Americas (2025)

    Fulltext@MSK | Save
  • Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): A single-arm, open-label, phase 1, dose-escalation study
    Journal Article

    Iyer, S. P.; Sica, R. A.; Ho, P. J.; Prica, A.; Zain, J.; Foss, F. M.; Hu, B.; Beitinjaneh, A.; Weng, W. K.; Kim, Y. H.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • High-risk features associated with recurrence in stage I lung adenocarcinoma
    Journal Article

    Fick, C. N.; Dunne, E. G.; Vanstraelen, S.; Toumbacaris, N.; Tan, K. S.; Rocco, G.; Molena, D.; Huang, J.; Park, B. J.; Rekhtman, N.; more...
    Journal of Thoracic and Cardiovascular Surgery (2025)

    Fulltext@MSK | Save
  • Consolidation ALK tyrosine kinase inhibitors versus durvalumab or observation after chemoradiation in unresectable stage III ALK-positive NSCLC
    Journal Article

    Nassar, A. H.; Jayakrishnan, R.; Feng, J.; Shepherd, F.; Adib, E.; Cheung, J. M.; Lin, J. J.; Liu, Y.; Lin, S. H.; Parikh, K.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save